Fig. 2From: Genotype characterization and delayed loss of ambulation by glucocorticoids in a large cohort of patients with Duchenne muscular dystrophyAge at LOA in the different DMD mutation subgroups. The black line indicates the “other deletions” subgroup with deletions not amenable to skipping of exons 44, 45, 51, or 53, as well as exon 3–7 deletion. The red line indicates the nonsense-mutation subgroup. The blue line indicates the “deletions amenable to skipping of exon 44” subgroup. The Navajo white line indicates the “deletions amenable to skipping of exon 45” subgroup. The cyan line refers to the “deletions amenable to skipping of exon 51” subgroup. The purple line indicates the “deletions amenable to skipping of exon 53” subgroup. The brown line indicates the exon 3–7 deletion subgroup. The “other deletions” subgroup was the reference group, and participants with deletions amenable to skipping of exon 44, exon 45, exon 51, exon 53, deletion of exon 3–7, and nonsense mutations were compared with the reference group. All participants in each mutation group were included. LOA loss of ambulation, DMD Duchenne muscular dystrophyBack to article page